MRI in autosomal dominant polycystic kidney disease.

Biomarkers / analysis Disease Progression Humans Magnetic Resonance Imaging / methods Polycystic Kidney, Autosomal Dominant / complications Predictive Value of Tests
ADPKD arachnoid cyst infected cyst pancreatic cyst total kidney volume venous compression

Journal

Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850

Informations de publication

Date de publication:
07 2019
Historique:
received: 25 10 2018
revised: 05 12 2018
accepted: 08 12 2018
pubmed: 15 1 2019
medline: 15 8 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Magnetic resonance imaging (MRI) is increasingly used in autosomal dominant polycystic kidney disease (ADPKD) for diagnosis, classification, assessment of disease progression and treatment response, and for identifying complications. Herein we review the role of MRI in the management of patients with ADPKD. We show how MRI-derived total kidney volume is a biomarker for assessing ADPKD severity and predicting decline in renal function. We also demonstrate the MR appearances of common complications. Level of Evidence: 3 Technical Efficacy Stage: 5 J. Magn. Reson. Imaging 2019;50:41-51.

Identifiants

DOI: 10.1002/jmri.26627 PMID: 30637853
pubmed: 30637853
doi: 10.1002/jmri.26627
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-51

Informations de copyright

© 2019 International Society for Magnetic Resonance in Medicine.

Auteurs

Weiguo Zhang (W)

Department of Radiology, Weill Cornell Medicine, New York, New York, USA.

Jon D Blumenfeld (JD)

Rogosin Institute, and Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Martin R Prince (MR)

Department of Radiology, Weill Cornell Medicine, New York, New York, USA.
Columbia College of Physicians and Surgeons, New York, New York, USA.
ORCID: 0000-0002-9883-0584

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › MRI in autosomal dominant polycystic kidney disease.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › MRI in autosomal dominant polycystic kidney disease.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › MRI in autosomal dominant polycystic kidney disease.
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › MRI in autosomal dominant polycystic kidney disease.
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Ciliopathies › Polykystoses rénales › Polykystose rénale autosomique dominante › MRI in autosomal dominant polycystic kidney disease.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › MRI in autosomal dominant polycystic kidney disease.